NCT05810506

Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements

Name: Clinical Trial NCT05810506
Creator: Bandırma Onyedi Eylül University
Keywords: Non-Alcoholic Fatty Liver Disease, In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention., other, clinical trial, Turkey

Evaluation of Anthropometric Measurements and Biochemical Parameters in Non-Alcoholic Fatty Liver Patients and Healthy Individuals

Bandırma Onyedi Eylül University·ClinicalTrials.gov·otherCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Non-Alcoholic Fatty Liver Disease
Drug/Device/Intervention: In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Bandırma Onyedi Eylül University
Location: Bandırma, Turkey

Timeline & enrollment

Phase: N/A
Start date: Oct 01, 2021
End date: Mar 17, 2023
Enrollment: 82 participants

Primary outcome

Body weight,Height,Body fat percentage,Neck circumference,Waist circumference,Hip circumference,Body mass index,Waist-to-length ratio,Waist to hip ratio,Body shape index,Body roundness index,Visceral adiposity index

Summary

The aim of this study; Which anthropometric measurement and ratio (BMI, waist circumference, hip circumference, waist-to-hip ratio, neck circumference, waist-height ratio, body shape index, body roundness index, visceral adiposity index) is a better indicator in healthy individuals with NAFLD and their biochemical parameters is to evaluate.

ICD-10 classifications

Alcoholic fatty liverAlcoholic liver disease, unspecifiedAlcoholic liver diseaseLiver disease, unspecifiedAlcoholic cirrhosis of liver

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05810506
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05810506 through Pure Global AI's free database. This phase not specified trial is sponsored by Bandırma Onyedi Eylül University and is currently Completed. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 82 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.